Video from AACC: Siemens Healthineers’ NAFLD test

By Leo O'Connor, Editor in Chief

July 28, 2022 -- Siemens Healthineers CMO Charles Cooper spoke to us about the firm’s Enhanced Liver Fibrosis blood test and how it can be used to assess the risk of nonalcoholic fatty liver disease (NAFLD) progression and liver-related events.

Click on the video below for the interview.

Siemens Healthineers at AACC
Siemens Healthineers CMO Charles Cooper.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.